Concourse Financial Group Securities’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Hold |
0
| – | – | – | 10531 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 10173 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 9944 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 9712 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 9467 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 9247 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 8895 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 8903 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 8709 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 8548 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8351 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8089 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7683 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7332 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7027 |
|